Mitochondrial dysfunction in metabolic syndrome.
Prasun P.
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165838. doi: 10.1016/j.bbadis.2020.165838. Epub 2020 May 16.
Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
Vrentzos E, Ikonomidis I, Pavlidis G, Katogiannis K, Korakas E, Kountouri A, Pliouta L, Michalopoulou E, Pelekanou E, Boumpas D, Lambadiari V.
Cardiovasc Diabetol. 2024 Jul 10;23(1):245. doi: 10.1186/s12933-024-02326-8.
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.
Lee HH, Lee HA, Kim EJ, Kim HY, Kim HC, Ahn SH, Lee H, Kim SU.
Gut. 2024 Feb 23;73(3):533-540. doi: 10.1136/gutjnl-2023-331003.
Cocaine use may modify HIV/ART-associated myocardial steatosis and hepatic steatosis.
Lai S, Gerstenblith G, Moore RD, Celentano DD, Bluemke DA, Treisman G, Liu CY, Li J, Chen S, Kickler T, Lai H.
Drug Alcohol Depend. 2017 Aug 1;177:84-92. doi: 10.1016/j.drugalcdep.2017.03.029. Epub 2017 May 26.
An overview of obesity-related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes.
Blüher M.
Diabetes Obes Metab. 2025 Apr;27 Suppl 2(Suppl 2):3-19. doi: 10.1111/dom.16263. Epub 2025 Mar 11.
Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study.
Kim KS, Hong S, Han K, Park CY.
BMJ. 2024 Feb 13;384:e076388. doi: 10.1136/bmj-2023-076388.
Multi-system diseases and death trajectory of metabolic dysfunction-associated fatty liver disease: findings from the UK Biobank.
Jia Y, Li D, You Y, Yu J, Jiang W, Liu Y, Zeng R, Wan Z, Lei Y, Liao X.
BMC Med. 2023 Oct 20;21(1):398. doi: 10.1186/s12916-023-03080-6.
Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction.
Chin Y, Lim J, Kong G, Ng CH, Goh R, Muthiah M, Mehta A, Chong B, Lin C, Chan KE, Kong W, Poh KK, Foo R, Chai P, Yeo TC, Low AF, Lee CH, Tan HC, Chan MY, Richards AM, Loh PH, Chew NWS.
Diabetes Obes Metab. 2023 Apr;25(4):1032-1044. doi: 10.1111/dom.14950. Epub 2023 Jan 6.
Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
Simon TG, Roelstraete B, Hagström H, Sundström J, Ludvigsson JF.
Gut. 2022 Sep;71(9):1867-1875. doi: 10.1136/gutjnl-2021-325724. Epub 2021 Sep 6.
Reye's syndrome.
Devivo DC, Keating JP.
Adv Pediatr. 1976;22:175-229.
